Terminology Service < Semantic Lookup Platform

All terms in EFO

Label	Id	Description
cystic neoplasm	MONDO_0021077	[A benign or malignant neoplasm that contains a single or multiple cystic spaces. Examples include cystadenoma, mucinous cystadenocarcinoma, and serous cystadenocarcinoma.]
diacylglycerol 38:5 measurement	EFO_0020067	[The quantification of diacylglycerol 38:5 levels in a sample, typically blood ]
HUES8	EFO_0007093	[Human embryonic stem cell line with a normal 46XY karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on KSR medium.]
obsolete_diacylglycerol 36:1 measurement	EFO_0020060	[The quantification of diacylglycerol 36:1 levels in a sample, typically blood ]
HUES66	EFO_0007092	[Human embryonic stem cell line derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, NANOG, and TRA-1-60. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.]
obsolete_diacylglycerol 36:2 measurement	EFO_0020061	[The quantification of diacylglycerol 36:2 levels in a sample, typically blood ]
HUES65	EFO_0007091	[Human embryonic stem cell line with a normal 46XY karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.]
diacylglycerol 36:3 measurement	EFO_0020062	[The quantification of diacylglycerol 36:3 levels in a sample, typically blood ]
HUES64-derived CD184+	EFO_0007090	[HUES64 cells were differentiated into CD184+ endothelial cells in feeder free conditions, using RPMI containing 100ng/mL of Activin A and 50ng/mL of Wnt3a, for 5 days. On day 5, the CD184 positive population was sorted via FACS. Cells come from a healthy male embryo provided by Harvard University.]
endothelial cell derived cell line	EFO_0005730	[An endothelial cell derived cell line is defined as a cell line that derives from an endothelial cell.]
diacylglycerol 36:4 measurement	EFO_0020063	[The quantification of diacylglycerol 36:4 levels in a sample, typically blood ]
iPS DF 4.7	EFO_0007097	[IPS DF 4.7 cell line is an induced pluripotent stem cell line, derived from newborn foreskin fibroblasts. Cells were received from the James Thomson laboratory, who originally reprogrammed the cells from fibroblasts provided by ATCC (Cat# CRL-2097TM). The first set of numbers before the period refer to different clones, the number after the period indicates the sub-clone. The differentiation method is described here: http://www.sciencemag.org/cgi/content/full/324/5928/797?rss=1]
iPS DF 19.11	EFO_0007096	[Human induced pluripotent stem cell line line derived from foreskin fibroblasts, isolated as described by Yu, J. et al. Human induced pluripotent stem cell lines free of vector and transgene sequences. Science 324, 797-801 (2009). Cells were received from the James Thomson laboratory, who originally reprogrammed the cells from fibroblasts provided by ATCC. The first set of numbers before the period refer to different clones, the number after the period indicates the sub-clone. Cells were maintained on mTeSR medium.]
uterine ligament neoplasm	MONDO_0021629	[A benign, borderline, or malignant neoplasm that affects the uterine ligaments. Representative examples include Wolffian adnexal tumor, papillary cystadenoma, and adenocarcinoma.]
ligament disorder	MONDO_0045044	[A disease or disorder that involves the ligament.]
iPS DF 19.7	EFO_0007095	[IPS DF 19.7 cell line is an induced pluripotent stem cell line, derived from newborn foreskin fibroblasts. Cells were received from the James Thomson laboratory, who originally reprogrammed the cells from fibroblasts provided by ATCC (Cat# CRL-2097TM). The first set of numbers before the period refer to different clones, the number after the period indicates the sub-clone. The differentiation method is described here: http://www.sciencemag.org/cgi/content/full/324/5928/797?rss=1]
HUES9	EFO_0007094	[Human embryonic stem cell line with an abnormal 46XX, Inv9 karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on KSR medium.]
iPS-11a	EFO_0007099	[Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: normal, 46XY [90%]; abnormal, extra marker chr [10%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4. [PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.]
iPS DF 6.9	EFO_0007098	[Human induced pluripotent stem cell line line derived from foreskin fibroblasts, isolated as described by Yu, J. et al. Human induced pluripotent stem cell lines free of vector and transgene sequences. Science 324, 797-801 (2009). Cells were received from the James Thomson laboratory, who originally reprogrammed the cells from fibroblasts provided by ATCC. The first set of numbers before the period refer to different clones, the number after the period indicates the sub-clone. Cells were maintained on mTeSR medium.]
brain astrocytoma	MONDO_0021631	[A astrocytoma (excluding glioblastoma) that involves the brain.]